Cargando…

Impaired type I interferon signaling activity implicated in the peripheral blood transcriptome of preclinical Alzheimer's disease

BACKGROUND: Subjective or objective subtle cognitive decline (SCD) is considered the preclinical manifestation of Alzheimer's disease (AD), which is a potentially crucial window for preventing or delaying the progression of the disease. METHODS: To explore the potential mechanism of disease pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Liting, Chen, Jingqi, Lo, Chun-Yi Zac, Guo, Qihao, Feng, Jianfeng, Zhao, Xing-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304603/ https://www.ncbi.nlm.nih.gov/pubmed/35863293 http://dx.doi.org/10.1016/j.ebiom.2022.104175

Ejemplares similares

Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
por: Song, Liting, et al.
Publicado: (2022)

Impaired type I interferon regulation in the blood transcriptome of recurrent asthma exacerbations
por: Gomez, Jose L., et al.
Publicado: (2018)

Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment
por: Huang, Yanlu, et al.
Publicado: (2022)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
por: Li, QinJie, et al.
Publicado: (2022)

Local Functional MR Change Pattern and Its Association With Cognitive Function in Objectively-Defined Subtle Cognitive Decline
por: Cui, Liang, et al.
Publicado: (2021)

Changes of Regional Neural Activity Homogeneity in Preclinical Alzheimer’s Disease: Compensation and Dysfunction
por: Zhang, Zhen, et al.
Publicado: (2021)

Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer’s disease
por: Hu, Hao, et al.
Publicado: (2021)

Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19
por: Xie, Xiaowei, et al.
Publicado: (2021)

Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer’s disease in mild cognitive impairment patients
por: Qian, Xiao-hang, et al.
Publicado: (2022)

Type I interferon (IFN)-inducible Absent in Melanoma 2 proteins in neuroinflammation: implications for Alzheimer’s disease
por: Choubey, Divaker
Publicado: (2019)

Type-I Interferons in Alzheimer's Disease and Other Tauopathies
por: Sanford, Sophie A. I., et al.
Publicado: (2022)

Impaired Mitochondrial and Glycolytic Functions in Peripheral Blood Leukocytes of Alzheimer’s Disease
por: Bharadwaj, Ravindra, et al.
Publicado: (2020)

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022)

Impaired Coronary Endothelial Vasorelaxation in a Preclinical Model of Peripheral Arterial Insufficiency
por: Arce-Esquivel, A.A, et al.
Publicado: (2015)

Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
por: Liang, Hai-Yong, et al.
Publicado: (2021)

Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease
por: Johansson, Maurits, et al.
Publicado: (2021)

Peripheral reaching in Alzheimer's disease and mild cognitive impairment
por: Mitchell, Alexandra G., et al.
Publicado: (2022)

Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials
por: Nuño, Michelle M., et al.
Publicado: (2019)

Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer’s disease
por: Qian, Shuxia, et al.
Publicado: (2021)

Association between handgrip strength and cognition in a Chinese population with Alzheimer’s disease and mild cognitive impairment
por: Su, Hang, et al.
Publicado: (2021)

A comprehensive transcriptomic analysis of alternate interferon signaling pathways in peripheral blood mononuclear cells in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2021)

Tracking the Main States of Dynamic Functional Connectivity in Resting State
por: Zhou, Qunjie, et al.
Publicado: (2019)

Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
por: Hadar, Adva, et al.
Publicado: (2018)

The type I interferon response in COVID-19: implications for treatment
por: Lee, Jeong Seok, et al.
Publicado: (2020)

MicroRNA Transcriptome of Poly I:C-Stimulated Peripheral Blood Mononuclear Cells Reveals Evidence for MicroRNAs in Regulating Host Response to RNA Viruses in Pigs
por: Wang, Jiying, et al.
Publicado: (2016)

Peripheral Nerve Impairment in a Mouse Model of Alzheimer’s Disease
por: Torcinaro, Alessio, et al.
Publicado: (2021)

Impaired interferon‐α expression in plasmacytoid dendritic cells in asthma
por: Lin, Ting‐Yu, et al.
Publicado: (2020)

Preclinical evidence for mitochondrial DNA as a potential blood biomarker for chemotherapy-induced peripheral neuropathy
por: Trecarichi, Annalisa, et al.
Publicado: (2022)

TYPE I INTERFERON-MEDIATED NEUROINFLAMMATORY PROGRAM AND SYNAPSE LOSS IN ALZHEIMER’S DISEASE
por: Roy, Ethan, et al.
Publicado: (2019)

Impairment of T and B Cell Development by Treatment with a Type I Interferon
por: Lin, Qun, et al.
Publicado: (1998)

Type I interferon responses are impaired in latently HIV infected cells
por: Ranganath, Nischal, et al.
Publicado: (2016)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

Transcriptomic Analysis Identifies Candidate Genes and Gene Sets Controlling the Response of Porcine Peripheral Blood Mononuclear Cells to Poly I:C Stimulation
por: Wang, Jiying, et al.
Publicado: (2016)

Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease
por: Zou, Chengyu, et al.
Publicado: (2016)

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2022)

Senescence Markers in Peripheral Blood Mononuclear Cells in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Salech, Felipe, et al.
Publicado: (2022)

Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease
por: Hooshmand, Kosar, et al.
Publicado: (2022)

Hibernation Impairs Odor Discrimination – Implications for Alzheimer’s Disease
por: Bullmann, Torsten, et al.
Publicado: (2019)

Impaired interferon-γ signaling promotes the development of silicosis
por: Peng, Zhouyangfan, et al.
Publicado: (2022)

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
por: Bertens, Daniela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4dn6ug5mgf3okatj17glsvakuo